Mentoring In IBD

@UCM2U8V0eGV9m2cuk_4V-Pnw - 116 subscribers

Mentoring in IBD presents the special edition IBD Dialogue series for gastroenterologists to discuss state-of-the-art management issues in inflammatory bowel disease. Volume 1 explores clinical questions surrounding the use of therapeutic drug monitoring. Volume 2 examines clinical questions and issues relating to the treat-to-target approach to therapy. All published issues of the educational newsletters are available at www.mentoringinibd.com. About Mentoring in IBD Mentoring in IBD is an innovative and successful educational curriculum for Canadian gastroenterologists that includes an annual national meeting, regional satellites in both official languages, a website, an educational newsletter series, and regular electronic communications answering key clinical questions with new research.

Home Videos Live Playlists

Treat-to-target strategy in pediatric patients with IBD – Anne M. Griffiths, MD

Treat-to-target strategy in pediatric patients with IBD – Anne M. Griffiths, MD Mentoring In IBD

409 views - 9 years ago

Early aggressive therapy can improve IBD outcomes – Brendan Halloran, MD

Early aggressive therapy can improve IBD outcomes – Brendan Halloran, MD Mentoring In IBD

1.2K views - 9 years ago

Importance of shared decision-making to the treat-to-target strategy – John K. Marshall, MD

Importance of shared decision-making to the treat-to-target strategy – John K. Marshall, MD Mentoring In IBD

203 views - 9 years ago

Extraintestinal manifestations of IBD and the treat-to-target strategy – A. Hillary Steinhart, MD

Extraintestinal manifestations of IBD and the treat-to-target strategy – A. Hillary Steinhart, MD Mentoring In IBD

513 views - 9 years ago

Utility of video capsule endoscopy in Crohn’s disease – Ernest G. Seidman, MD

Utility of video capsule endoscopy in Crohn’s disease – Ernest G. Seidman, MD Mentoring In IBD

679 views - 9 years ago

Transabdominal ultrasound in IBD – Kerri Novak, MD

Transabdominal ultrasound in IBD – Kerri Novak, MD Mentoring In IBD

1.4K views - 9 years ago

Monitoring in the treat-to-target strategy – Mark S. Silverberg, MD

Monitoring in the treat-to-target strategy – Mark S. Silverberg, MD Mentoring In IBD

257 views - 9 years ago

STRIDE treat-to-target recommendations – Mark S. Silverberg, MD

STRIDE treat-to-target recommendations – Mark S. Silverberg, MD Mentoring In IBD

919 views - 9 years ago

Benefits and risks of treat to target – John K. Marshall, MD

Benefits and risks of treat to target – John K. Marshall, MD Mentoring In IBD

252 views - 9 years ago

Role of fecal calprotectin in treat to target – Smita Halder, MD

Role of fecal calprotectin in treat to target – Smita Halder, MD Mentoring In IBD

2.8K views - 9 years ago

Treat to target and REACT – Brian G. Feagan, MD

Treat to target and REACT – Brian G. Feagan, MD Mentoring In IBD

677 views - 9 years ago

The “treat to target” concept – Richard N. Fedorak, MD

The “treat to target” concept – Richard N. Fedorak, MD Mentoring In IBD

840 views - 9 years ago

Patient benefits of using TDM - A. Hillary Steinhart, MD

Patient benefits of using TDM - A. Hillary Steinhart, MD Mentoring In IBD

436 views - 10 years ago

Avantages de l’utilisation de la pharmacovigilance thérapeutique pour le patient

Avantages de l’utilisation de la pharmacovigilance thérapeutique pour le patient Mentoring In IBD

56 views - 10 years ago

Physician benefits of using TDM - Niels Vande Casteele, PharmD PhD

Physician benefits of using TDM - Niels Vande Casteele, PharmD PhD Mentoring In IBD

1.2K views - 10 years ago

Avantages de l’utilisation de la pharmacovigilance thérapeutique pour le médecin

Avantages de l’utilisation de la pharmacovigilance thérapeutique pour le médecin Mentoring In IBD

101 views - 10 years ago

Rôle clinique de la pharmacovigilance thérapeutique dans l’évaluation de la réponse

Rôle clinique de la pharmacovigilance thérapeutique dans l’évaluation de la réponse Mentoring In IBD

86 views - 10 years ago

Clinical utility of TDM for monitoring response - Richard N. Fedorak, MD

Clinical utility of TDM for monitoring response - Richard N. Fedorak, MD Mentoring In IBD

231 views - 10 years ago

Pharmacovigilance thérapeutique : Gérer des concentrations élevées d’infliximab

Pharmacovigilance thérapeutique : Gérer des concentrations élevées d’infliximab Mentoring In IBD

35 views - 10 years ago

TDM: Managing high infliximab levels - Simon PL. Travis, MD

TDM: Managing high infliximab levels - Simon PL. Travis, MD Mentoring In IBD

700 views - 10 years ago

Pharmacovigilance thérapeutique : Gérer de faibles concentrations d’infliximab

Pharmacovigilance thérapeutique : Gérer de faibles concentrations d’infliximab Mentoring In IBD

81 views - 10 years ago

TDM: Managing low infliximab levels - Peter L. Lakatos, MD

TDM: Managing low infliximab levels - Peter L. Lakatos, MD Mentoring In IBD

574 views - 10 years ago

Interprétation des résultats de la pharmacovigilance thérapeutique

Interprétation des résultats de la pharmacovigilance thérapeutique Mentoring In IBD

45 views - 10 years ago

Interpretation of TDM results - Shomron Ben-Horin, MD

Interpretation of TDM results - Shomron Ben-Horin, MD Mentoring In IBD

741 views - 10 years ago

Choisir le moment de la pharmacovigilance thérapeutique

Choisir le moment de la pharmacovigilance thérapeutique Mentoring In IBD

61 views - 10 years ago

TDM timing - Peter L. Lakatos, MD

TDM timing - Peter L. Lakatos, MD Mentoring In IBD

487 views - 10 years ago

Clinical limitations of TDM - Peter L. Lakatos, MD

Clinical limitations of TDM - Peter L. Lakatos, MD Mentoring In IBD

243 views - 10 years ago

Limites cliniques de la pharmacovigilance thérapeutique

Limites cliniques de la pharmacovigilance thérapeutique Mentoring In IBD

36 views - 10 years ago

Intérêt clinique de la pharmacovigilance thérapeutique

Intérêt clinique de la pharmacovigilance thérapeutique Mentoring In IBD

138 views - 10 years ago

Évolution du traitement par l’infliximab

Évolution du traitement par l’infliximab Mentoring In IBD

1K views - 10 years ago

Techniques de pharmacovigilance thérapeutique au Canada

Techniques de pharmacovigilance thérapeutique au Canada Mentoring In IBD

162 views - 10 years ago

Variabilité individuelle dans les concentrations de l’infliximab

Variabilité individuelle dans les concentrations de l’infliximab Mentoring In IBD

154 views - 10 years ago

Clinical utility of TDM - Peter L. Lakatos, MD

Clinical utility of TDM - Peter L. Lakatos, MD Mentoring In IBD

272 views - 10 years ago

TDM assays in Canada - Remo Panaccione, MD

TDM assays in Canada - Remo Panaccione, MD Mentoring In IBD

1.1K views - 11 years ago

Individual variability in infliximab levels – Diane R. Mould, PhD

Individual variability in infliximab levels – Diane R. Mould, PhD Mentoring In IBD

1.5K views - 11 years ago

Evolution of infliximab therapy – John K. Marshall, MD

Evolution of infliximab therapy – John K. Marshall, MD Mentoring In IBD

801 views - 11 years ago